Universal Biosensors

Focus: Universal Biosensors is an Australian-headquartered diagnostics company specializing in molecular diagnostics and medical devices, operating as a public company with a focused portfolio in point-of-care testing.

Profile data last refreshed 12h ago · AI intelligence enriched 3w ago

Funding Stage

PUBLIC

Open Jobs

About Universal Biosensors

AI assessmentNot Hiring

No open roles listed right now. Follow Universal Biosensors to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

3/9 — Basic

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Study to Test the Accuracy of a Prototype Handheld PT/INR Device

Blood Coagulation Disorders

N/A

Clinical Trials (1)

NCT01349712Study to Test the Accuracy of a Prototype Handheld PT/INR Device

N/A

Help build intelligence for Universal Biosensors

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Public company status provides equity upside and career stability absent in early-stage biotech.
Focused presence in high-demand diagnostics segment with recurring revenue potential from point-of-care devices.
Opportunity to contribute to clotting disorder diagnostics with tangible clinical applications.

Watch Out For

No active job openings reported, indicating limited near-term hiring or potential organizational contraction.
Minimal pipeline visibility: only 2 studies in early-stage development with no Phase 1–3 programs, suggesting limited product velocity.
Sparse recent news and publication activity (5 publications) signal low market momentum and R&D output relative to competitors.

Generated by Claude from Universal Biosensors's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood

Clotting Disorders

N/A

Clinical Trials (1)

NCT01375725Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 2 clinical trials

Publications: 6 in PubMed

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Research Publications(6)

Recent peer-reviewed publications with author affiliations at this company

Hollow Cu/Zn-MOF@Au/Ferrocene Nanoarchitectures: A Universal Leap from Colorimetric to Dual-Mode Colorimetric/Electrochemical Lateral Flow Assays.

Analytical chemistry

2025

PMID:40751665

Stacking paper sheets into multi-purpose quick response sensing code with built-in nitrocellulose-membrane-free lateral flow assay for detecting tetracycline in food samples.

Food chemistry